NSF has released an updated version of the NSF Grants.gov Application Guide (NSF 24-006). In general, the Guide has been revised to match the changes in NSF's Proposal and Award Policies and Procedures Guide (PAPPG) (NSF 24-1). A summary of changes by chapter is provided at the beginning of the document. 

The guide will be effective for applications submitted (via Grants.gov) or due on or after May 20, 2024. The guidelines in grantsgovguide0123 are applicable to proposals submitted before May 20, 2024.

This notice provides the research and research training community with an overview of application and peer review changes impacting grant applications submitted for due dates on or after January 25, 2025, including:

•    Simplified Review Framework for Most Research Project Grant Applications
•    Revisions to the NIH Fellowship Application and Review Process
•    Updates to Reference Letter Guidance
•    Updates to NRSA Training Grant Applications
•    Updated Application Forms (FORMS-I)
•    Common Forms for Biographical Sketch and Current and Pending (Other) Support

NIH will provide more information and guidance on these initiatives throughout 2024, which will be referred to in this notice as well.

The purpose of this notice is to provide updates and plans for implementing the simplified peer review framework for most research project grant applications announced in October (NOT-OD-24-010). It updates and clarifies the activity codes impacted, the plans to update funding opportunities, and the timing of when application forms will be available.

NIH is on schedule to implement the simplified review framework for applications that have due dates on or after January 25, 2025.

The applicant and recipient communities are notified of changes to grant application forms and application guide instructions for due dates on or after January 25, 2025 through this notice.

The application forms below have substantial modifications (i.e., new/deleted/modified fields). All other forms are limited to an OMB expiration date change.

•    PHS 398 Research Training Program Plan
•    PHS Fellowship Supplemental Form
•    PHS Assignment Request Form
•    PHS 398 Cover Page Supplement Form

This notice informs about the modifications made to the application and peer review process for NIH and AHRQ fellowship applications beginning with submissions that are due after January 25, 2025. The overall goal of the changes is to facilitate the mission of fellowship peer review - to identify the most promising candidates and provide individualized training opportunities that will assist them along their path to support the advancement of the biomedical research enterprise.

My bibliography contains information on eRA Commons users who have received grants in their portfolio. They are able to determine whether their publications comply with the NIH Public Access Policy, initiate the compliance process and link their publications to NIH extramural awards. The steps to manage compliance with the NIH public access policy can be found here.

Pre-announcements released:

The Neurofibromatosis Research Program (NFRP) released a pre-announcement for the following funding opportunities:

·      Neurofibromatosis Research Academy – Leadership Award

·      Clinical Trial Award

·      Exploration – Hypothesis Development Award

·      Early Investigator Research Award

·      Investigator-Initiated Research Award

·      New Investigator Award

·      Synergistic Idea Award

To view the pre-announcement, click here.

Funding announcements released:

The Amyotrophic Lateral Sclerosis Research Program (ALSRP) released program announcements for the following funding opportunities:

·      Clinical Outcomes and Biomarkers Award

·      Pilot Clinical Trial Award

·      Therapeutic Development Award

·      Therapeutic Idea Award

To view the program announcements and submit a pre-application, click here. 

The Autism Research Program (ARP) released program announcements for the following funding opportunities:

·      Career Development Award

·      Clinical Trial Award

·      Idea Development Award

To view the program announcements and submit a pre-application, click here.

The Epilepsy Research Program (ERP) released program announcements for the following funding opportunities:

·      Leveraging Research Award

·      Virtual Post-Traumatic Epilepsy Research Center (P-TERC) – Faulty Award

·      Idea Development Award

·      Research Partnership Award

To view the program announcements and submit a pre-application, click here.

The Hearing Restoration Research Program (HRRP) released program announcements for the following funding opportunity:

·      Focused Research Award

To view the program announcement and submit a pre-application, click here.

The Peer Reviewed Alzheimer's Research Program (PRARP) released program announcements for the following funding opportunities:

·      Transforming Care Award

·      Transforming Diagnosis Award

·      Transforming Research Award

To view the program announcements and submit a pre-application, click here.

The Spinal Cord Injury Research Program (SCIRP) released program announcements for the following funding opportunities:

·      Clinical Trial Award

·      Clinical Translation Research Award

·      Translational Research Award

·      Investigator-Initiated Research Award

To view the program announcements and submit a pre-application, click here.

The Vision Research Program (VRP) released program announcements for the following funding opportunity:

·      Mentored Clinical Research Award

To view the program announcements and submit a pre-application, click here.

The Breast Cancer Research Program (BCRP) released program announcements for the following funding opportunities:

·       Breakthrough Award Levels 1 and 2

·       Breakthrough Award Level 3

·       Breakthrough Award Level 4

·       Clinical Research Extension Award

·       Era of Hope Scholar Award

·       Transformative Breast Cancer Consortium Award

·       Transformative Breast Cancer Consortium Development Award

While the Breakthrough Award Level 3, Breakthrough Award Level 4, and Transformative Breast Cancer Consortium Award mechanisms were released twice per fiscal year during recent years, it is anticipated that these three mechanisms will be released once for FY24. If interested in applying to these three FY24 mechanisms, investigators are strongly encouraged to apply to the current funding opportunities for which pre-applications are due 14 May 2024.

To view the program announcements and submit a pre-application, click here.

The Lung Cancer Research Program (LCRP) released program announcements for the following funding opportunities:

·       Concept Award

·       Career Development Award

·       Idea Development Award

·       Translational Research Award

·       Patient-Centered Outcomes and Survivorship Award

To view the program announcements and submit a pre-application, click here.

The Ovarian Cancer Research Program (OCRP) released program announcements for the following funding opportunities:

·       Pilot Award

·       Investigator- Initiated Research Award

·       Clinical Trial Award

·       Clinical Trial Translational Endpoints Research Award ** (NEW)

·       Ovarian Cancer Academy – Leadership Award

·       Ovarian Cancer Academy – Early-Career Investigator Award

To view the program announcements and submit a pre-application, click here.

Due April 29, 2024

Amount: $750,000 over three years

These grants are awarded to outstanding early career investigators to support high-impact, high-risk projects that are distinct from their current research portfolio. This award is not intended to be the main source of funding for the applicant’s lab. Applicants must demonstrate multi-year independent funding that sustains the central activities of the lab.

Projects must be centered on evidence-based laboratory, data, and/or medical science.

Eligibility: MD, PhD or equivalent is required; Must be 3 to 8 years from the start of an independent faculty research appointment as of 12/31/2024.

The Pew Scholars Program in the Biomedical Sciences provides funding to support assistant professors who, based on their performance during their education and training, demonstrate outstanding promise as contributors in science relevant to the advancement of human health. Awards are $75,000 per year for 4 years. Einstein may nominate ONE candidate for the 2025 Pew Scholars Program.  

Eligibility criteria: 

• Candidates must have been awarded a doctorate in biomedical sciences, medicine, or a related field. 
• As of Sept. 5, 2024, nominees must be running an independent lab and hold full-time appointments at the rank of assistant professor or equivalent. Appointments such as research assistant professor, adjunct assistant professor, assistant professor research track, visiting professor, or instructor are NOT eligible. 

Candidates must NOT have been appointed as an assistant professor at any institution prior to June 10, 2020, whether or not such appointment was on a tenure track. Time spent on clinical internships, residencies, on work towards board certification, or on parental leave does not count as part of this four-year limit. 

The deadline for submission of preliminary applications for internal review by Einstein’s Awards Committee is 5 PM, Wednesday, May 1st, 2024. Please send ONE PDF file containing the following as an email attachment to Indranil.basu@einsteinmed.edu: 

• Candidate Profile Form (click here). 
• A statement outlining the applicant’s career potential and the Department’s plans for his/her future to be obtained from the Department Chairperson, limited to no more than TWO single-spaced pages.  
• A written proposal containing a title and a description of the proposed research project to be carried out during the grant period, limited to no more than THREE single-spaced pages, plus one additional page (single-spaced) for references with titles included. The font should be 11-point or larger, and the margins should be at least 0.5 inches. Figure legends can use smaller fonts.  
• A complete curriculum vitae and bibliography. Do NOT submit an NIH biosketch. 
• Information about present and pending grant support with amounts requested or approved, annual amounts, and duration of award. 

Complete guidelines for this program can be found by clicking here.

If you have any questions concerning this award or the application procedure, please contact Indranil.basu@einsteinmed.edu.

The Pew-Stewart Scholars for Cancer Research aids assistant professors with exceptional promise in science that is crucial for the advancement of a cure for cancer. Awards are $75,000 per year for 4 years. Einstein may nominate ONE candidate for the 2025 Pew-Stewart Scholars Program for Cancer Research. Applications are invited from candidates conducting cancer research. This program is not the same as the Pew Scholars Program, and it follows a different but parallel set of guidelines and procedures for nominating an applicant whose research is related to cancer. The same applicant cannot apply for both programs at the same time. Please indicate in your application which program you are applying for: Biomedical Sciences (Pew Scholars) or Cancer Research (Pew-Stewart Scholars).

Eligibility criteria: 

Candidates must have been awarded a doctorate in biomedical sciences, medicine, or a related field, including engineering or the physical sciences. 

As of Aug. 28, 2024, nominees must be running an independent lab and hold full-time appointments at the rank of assistant professor or equivalent. Appointments such as research assistant professor, adjunct assistant professor, assistant professor research track, visiting professor, or instructor are NOT eligible. 

Candidates must NOT have been appointed as an assistant professor at any institution prior to June 10, 2020, whether or not such appointment was on a tenure track. Time spent on clinical internships, residencies, on work towards board certification, or on parental leave does not count as part of this four-year limit. 

The deadline for submission of preliminary applications for internal review by Einstein’s Awards Committee is 5 PM, Wednesday, May 1st, 2024. Please send ONE PDF file containing the following as an email attachment to Indranil.basu@einsteinmed.edu: 

• Candidate Profile Form (click here).
• A statement outlining the applicant’s career potential and the Department’s plans for his/her future to be obtained from the Department Chairperson, limited to no more than TWO single-spaced pages.  
• A written proposal containing a title and a description of the proposed research project to be carried out during the grant period, limited to no more than THREE single-spaced pages, plus one additional page (single-spaced) for references with titles included. The font should be 11-point or larger, and the margins should be at least 0.5 inches. Figure legends can use smaller fonts.  
• A complete curriculum vitae and bibliography. Do NOT submit an NIH biosketch. 
• Information about present and pending grant support with amounts requested or approved, annual amounts, and duration of award. 

Complete guidelines for this program can be found by clicking here.

If you have any questions concerning this award or the application procedure, please contact Indranil.basu@einsteinmed.edu.

Due: May 6, 2024 (LOI)

• Amount: $390,000 over 3 years

• Notes: To support established researchers for research relevant to Inflammatory Bowel Disease (IBD) or Crohn’s disease and/or ulcerative colitis. Funding should be used to generate sufficient preliminary data to become competitive for funds from other sources, such as the National Institutes of Health (NIH). Applicants must hold an MD and/or PhD (or equivalent). Eligibility is not restricted by citizenship.

• Link: Senior Research Awards | Crohn's & Colitis Foundation (crohnscolitisfoundation.org).

For further details, please contact Audrey Mcinerney (amcinerney@montefiore.org).

Due: May 10, 2024 (pre-application)

• Amount: $600,000 over 5 years

• Notes: To foster the development and productivity of young scientists who have potential to make significant contributions to MS research and help ensure the future and stability of MS research. The award provides approximately $600,000 over five years to support a two-year period of advanced postdoctoral training in MS research and the first three years of research support in a new faculty appointment. Applicants must have more than two years of postdoctoral research experience and no more than five years of postdoctoral research experience at the time of application.

• Link: Career Transition Fellowships | National MS Society

For further details, please contact Audrey Mcinerney (amcinerney@montefiore.org).

• Due: May 14, 2024
• Amount: $240,000/2 years
• Clinical research areas include cancer (hematology and oncology), cardiovascular disease and immunologic disorders. The award is designed to support the career development of early-stage investigator physicians from diverse backgrounds, and physicians with a demonstrated commitment to increasing diversity in clinical research, to become independent clinical trial investigators engaged in advancing health equity. Grantees are required to receive mentorship from a seasoned clinical investigator at a clinical trial site or institution and are expected to actively participate in their mentor’s clinical trial, which must meet the FDA Clinical Trial Definition. Scholars aren’t expected to run their own trials.



• Eligibility: Candidates must hold the degree of either MD, MD/PhD, DO or DO/PhD. Must be US citizen, permanent resident, or hold an H-1B or O-1 visa, which must be valid during the full award period. Must have completed terminal research degree or medical residency (whichever later) within the past 10 years. You don’t have to fall under URM population to participate; you may apply with a demonstrated commitment to increasing diverse patient populations in clinical trials. A mentor who will provide guidance on career development focusing on challenges, opportunities, and strategies for researchers from underserved backgrounds is required.
• For further details, please contact Audrey Mcinerney (amcinerney@montefiore.org).

Due: May 15, 2024

• Amount: Up to $8.6M over 10 years

• Notes: to support outstanding basic researchers, including physician-scientists, who have strong potential to become leaders in their fields and to advance diversity, equity, and inclusion through their mentoring efforts and understanding of systemic exclusion and marginalization in science of trainees from different backgrounds. Scholars prioritize scientific excellence in their own research while creating an inclusive lab climate that serves as a model within their own institutions and beyond. Freeman Hrabowski Scholars are employed by HHMI and maintain an academic appointment and lab at their research institutions. Scholars are required to spend at least 80 percent of their time on their research.

• Eligibility: PI must hold MD or PhD or equivalent; began their first post-training position and a tenure-track (or equivalent) faculty position on or after March 1, 2020, or have accepted an offer for a tenure-track (or equivalent) position that begins no later than March 1, 2025; have a research focus in the biological and biomedical sciences.

• Link: Freeman Hrabowski Scholars Program | HHMI

For further details, please contact Audrey Mcinerney (amcinerney@montefiore.org).

Due: May 15, 2024 (LOI)

• Amount: $250,000 over 2 years

• Notes: Proposed research “must be translational in nature and relate to the field of maternal fetal health – with a focus on prematurity, maternal and infant morbidity and mortality and health equity.” PI Must be seeking a career in academic obstetrics and gynecology research. Applicants must be near completion of their residency in obstetrics and gynecology or in their subspecialty fellowship. Any individual with the skills, knowledge, and resources necessary to carry out the proposed research is invited to work with their institution to develop an application for support. Prior laboratory experience is not required.

• Link: Reproductive Scientist Development Program | March of Dimes

For further details, please contact Audrey Mcinerney (amcinerney@montefiore.org).

Grant Amount: $206,000 USD

Grant Term: 2 Years

Start of Grant Term: September 1, 2024

Application Deadline: May 15, 2024 1:00 PM

Decision Date: August 2024

Additional information about this grant can be obtained from the Program Guidelines and Applications Instructions. Final eligibility determinations will not be completed until the AACR receives the submitted application.

Applicants must be female investigators with a doctoral degree (PhD, MD, MD/PhD, or equivalent) in a related field and not currently be a candidate for a further doctoral degree. Applicants belonging to racial or ethnic groups shown to be underrepresented in the cancer-related sciences workforce are especially encouraged to apply. 

At the start of the grant term on September 1, 2024, applicants must:

·      Hold a faculty position with the title of assistant professor. Appointments such as research assistant professor, adjunct assistant professor, and assistant professor research track are eligible. Applicants that have progressed to associate professor or equivalent appointments are not eligible.

o  If eligibility is based on a future position, the position must be confirmed at the time of application and CANNOT be contingent upon receiving this grant.

·      Have started their first independent faculty position within the past 6 years from the grant start date (i.e. cannot have held an independent faculty position before September 1, 2018).

·      Must devote at least 75% of their total effort to research in breast or a gynecologic cancer.

·      Have independent laboratory space as confirmed by their institution.

Due: May 27, 2024

• Amount: $250,000/1 year

• Notes: The foundation is seeking projects focused on tumors of the upper GI tract. Proposals should aim to drive disruptive research, with the goal of advancing the field of gastric and esophageal cancer research and ultimately improving patient outcomes. Proposals should cover topics such as understanding the molecular mechanisms underlying tumor initiation and progression, resistance, and metastasis; identifying novel biomarkers for early detection; and developing innovative treatment strategies including identifying and characterizing novel targets. PIs must be independent researchers at their respective institutions. Proposals from investigators at all career stages, especially those new to the field of upper GI cancers, are welcome. To facilitate this, preclinical resources (cell lines, organoids, and mouse models) will be made available to researchers who request them. Interdisciplinary collaborations are encouraged. Researchers are limited to one application as PI but may be co-investigators on other proposals without limitations.

• Link: ASPIRE Award

• Webinar on May 1 at 12 pm, describing application process and award.

Due: June 3, 2024 (LOI)

Amount: $600,000 over 2 years

• Notes: Program is dedicated to advancing academic discoveries into medicines for Alzheimer’s disease and related dementias. This unique award provides funding and project support by a team of pharmaceutical industry experts through a collaboration with the Alzheimer’s Drug Discovery Foundation (ADDF) and the Brain Health Medicines Centers of the Harrington Discovery Institute.

Lead investigator must have an MD, a PhD, or equivalent. Proposals should show potential to advance discovery into meaningful therapeutics to treat, prevent, slow, or reverse Alzheimer’s disease or related dementias (vascular dementia, frontotemporal dementia, Lewy Body dementia, LATE etc).

Team should possess intellectual property (IP) or have potential for novel IP that has not yet been licensed to a for-profit entity. Researchers working on drug development programs that are relevant to but not presently focused on the Alzheimer’s field are strongly encouraged to apply. Therapeutic targets with a clear marker of target engagement, either established or in development will be considered of high priority.

The ADDF-Harrington Scholar Program does not support target discovery, assay development, or high throughput screening campaigns.



• Link: ADDF-Harrington Scholar Program | Alzheimer's Drug Discovery Foundation

(alzdiscovery.org)

Sponsored by the Josiah Macy Jr. Foundation, the Macy Faculty Scholars Program, a prestigious national award, is designed to develop and advance the careers of junior faculty medical educators. The Scholars Program annually competitively selects and funds FIVE scholars from across the nation. Albert Einstein College of Medicine may nominate ONE faculty member for consideration for the 2025 Program. Awards are intended to cover 50% protected time up to a cap of $100,000 per year for 2 years.

Eligibility criteria: 

·     Candidates must have been awarded a doctorate in medicine, biomedical sciences, or a related field. 

·     Nominees must be hold full-time appointments at the rank of assistant or associate professor or equivalent. Appointments such as research assistant professor, adjunct assistant professor, assistant professor research track, visiting professor, or instructor are NOT eligible. 

·     Candidates must NOT have been appointed as faculty at any institution prior to July 1, 2015, whether or not such appointment was on a tenure track. Time spent on clinical internships, residencies, on work towards board certification, or on parental leave does not count as part of this eight-year limit. 

SAVE THE DATE: An informational webinar for applicants will be held by the Josiah Macy Jr Foundation on Wednesday, May 29 at 1:00 pm ET. RSVP Today

Application Materials

Note: The deadline for submission of preliminary applications for internal review by Einstein’s Education Awards Committee is 5 PM, June 26, 2023.

Please send ONE PDF file containing the following as an email attachment to susan.legnini@einsteinmed.edu.  

·     Candidate Profile Form (click here). 

·     A statement by the applicant on career objectives and personal goals for this program, limited to no more than TWO single-spaced pages.

·     A mentor’s statement outlining the applicant’s career potential, limited to no more than ONE single-spaced page.

·     A Departmental letter of support limited to no more than TWO single-spaced pages.  

·     A written proposal containing a title and a description of the proposed educational scholarship project to be carried out during the grant period, limited to no more than THREE single-spaced pages, plus one additional page (single-spaced) for references with titles included. The font should be 11-point or larger, and the margins should be at least 0.5 inches. Figure legends can use smaller fonts.  

·     A complete curriculum vitae and bibliography. Do NOT submit an NIH biosketch. 

·     Information about present and pending grant support with amounts requested or approved, annual amounts, and duration of award. 

Complete guidelines for this program can be accessed by clicking here.

If you have any questions concerning this award or the application procedure, please contact susan.legnini@einsteinmed.edu.